256 related articles for article (PubMed ID: 9141208)
1. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
[TBL] [Abstract][Full Text] [Related]
2. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.
Yang C; Collins WE; Sullivan JS; Kaslow DC; Xiao L; Lal AA
Infect Immun; 1999 Jan; 67(1):342-9. PubMed ID: 9864235
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax.
Collins WE; Sullivan JS; Morris CL; Galland GG; Jue DL; Fang S; Wohlhueter R; Reed RC; Yang C; Hunter RL; Lal AA
Am J Trop Med Hyg; 1997 Feb; 56(2):200-10. PubMed ID: 9080881
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys.
Collins WE; Kaslow DC; Sullivan JS; Morris CL; Galland GG; Yang C; Saekhou AM; Xiao L; Lal AA
Am J Trop Med Hyg; 1999 Mar; 60(3):350-6. PubMed ID: 10466960
[TBL] [Abstract][Full Text] [Related]
5. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.
Charoenvit Y; Collins WE; Jones TR; Millet P; Yuan L; Campbell GH; Beaudoin RL; Broderson JR; Hoffman SL
Science; 1991 Feb; 251(4994):668-71. PubMed ID: 1704150
[TBL] [Abstract][Full Text] [Related]
6. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
Collins WE; Nussenzweig RS; Ruebush TK; Bathurst IC; Nardin EH; Gibson HL; Campbell GH; Barr PJ; Broderson JR; Skinner JC
Am J Trop Med Hyg; 1990 Dec; 43(6):576-83. PubMed ID: 1702586
[TBL] [Abstract][Full Text] [Related]
9. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
Collins WE; Nussenzweig RS; Ballou WR; Ruebush TK; Nardin EH; Chulay JD; Majarian WR; Young JF; Wasserman GF; Bathurst I
Am J Trop Med Hyg; 1989 May; 40(5):455-64. PubMed ID: 2658634
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
[TBL] [Abstract][Full Text] [Related]
11. Testing of Plasmodium vivax CS proteins in Saimiri monkeys.
Collins WE
Bull World Health Organ; 1990; 68 Suppl(Suppl):42-6. PubMed ID: 2094590
[TBL] [Abstract][Full Text] [Related]
12. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
13. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
Whitacre DC; Espinosa DA; Peters CJ; Jones JE; Tucker AE; Peterson DL; Zavala FP; Milich DR
PLoS One; 2015; 10(5):e0124856. PubMed ID: 25933001
[TBL] [Abstract][Full Text] [Related]
14. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
15. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
[TBL] [Abstract][Full Text] [Related]
16. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1).
Yang C; Collins WE; Xiao L; Patterson PS; Reed RC; Hunter RL; Kaslow DC; Lal AA
Parasite Immunol; 1996 Nov; 18(11):547-58. PubMed ID: 9226693
[TBL] [Abstract][Full Text] [Related]
17. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques.
Vanloubbeeck Y; Pichyangkul S; Bayat B; Yongvanitchit K; Bennett JW; Sattabongkot J; Schaecher K; Ockenhouse CF; Cohen J; Yadava A;
Vaccine; 2013 Dec; 31(52):6216-24. PubMed ID: 24144477
[TBL] [Abstract][Full Text] [Related]
19. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
